Medical School · Year 1 · Foundations · includes a quiz and discussion video

Lecture 6: Carbohydrate Metabolism II - The TCA Cycle

Unit 1.1: Foundations of Medicine & Medical Sciences

Learning Objectives

By the end of this lecture, students will be able to:

1. Describe the eight reactions of the citric acid cycle, including substrates, products, and enzymes
2. Explain the regulatory points of the TCA cycle and the factors that control flux through the pathway
3. Calculate the total energy yield from the complete oxidation of one acetyl-CoA
4. Connect the TCA cycle to electron transport through NADH and FADH₂ production
5. Describe the anaplerotic reactions that replenish TCA cycle intermediates
6. Identify clinical conditions related to TCA cycle dysfunction

Lecture Content

I. Introduction to the TCA Cycle

The tricarboxylic acid (TCA) cycle—also known as the citric acid cycle or Krebs cycle after Hans Krebs, who elucidated the pathway in 1937 (earning the Nobel Prize in 1953)—represents the final common pathway for the oxidation of fuel molecules. Whether the body burns carbohydrates, fats, or proteins, the carbon skeletons ultimately converge as acetyl-CoA and enter this central metabolic wheel located in the mitochondrial matrix.

The cycle serves two fundamental purposes. First, it completes the oxidation of acetyl groups to carbon dioxide, capturing the released energy in the form of reduced coenzymes (NADH and FADH₂) that drive ATP synthesis through oxidative phosphorylation. Second, it provides essential intermediates for biosynthetic pathways—the cycle is therefore described as amphibolic, serving both catabolic (breakdown) and anabolic (biosynthetic) functions.

The overall reaction summarizes what one turn of the cycle accomplishes: Acetyl-CoA + 3 NAD⁺ + FAD + GDP + Pᵢ + 2 H₂O → CoA-SH + 3 NADH + 3 H⁺ + FADH₂ + GTP + 2 CO₂. The two-carbon acetyl unit is completely oxidized to two molecules of carbon dioxide, with the captured electrons appearing in three NADH and one FADH₂. One high-energy phosphate bond (as GTP) is produced directly through substrate-level phosphorylation.

<image>Panel A: TCA cycle entry showing acetyl-CoA (green 2C) condensing with oxaloacetate (blue 4C) to form citrate (6C). Panel B: First half of cycle from citrate through isocitrate to alpha-ketoglutarate (5C) with first CO2 release (red) and NADH production (purple). Panel C: Second CO2 release at alpha-ketoglutarate dehydrogenase producing succinyl-CoA (4C) with NADH and GTP production at step 5. Panel D: Cycle completion through succinate (FADH2 at step 6), fumarate, malate, back to oxaloacetate with third NADH at step 8.</image>

II. Entry into the TCA Cycle: Pyruvate Dehydrogenase Complex

Before acetyl-CoA can enter the TCA cycle, pyruvate from glycolysis must be converted to acetyl-CoA. This critical reaction, catalyzed by the pyruvate dehydrogenase (PDH) complex, represents the irreversible commitment of carbon atoms to oxidation—there is no pathway to convert acetyl-CoA back to pyruvate in mammals.

The PDH Reaction

The pyruvate dehydrogenase complex catalyzes the oxidative decarboxylation of pyruvate: Pyruvate + NAD⁺ + CoA-SH → Acetyl-CoA + CO₂ + NADH + H⁺. This reaction occurs in the mitochondrial matrix and represents the first carbon dioxide released during glucose oxidation (though technically not part of the TCA cycle proper). Each glucose molecule generates two pyruvates, so this reaction occurs twice per glucose, producing two acetyl-CoA, two NADH, and two CO₂.

Structure of the PDH Complex

The pyruvate dehydrogenase complex is a massive molecular machine composed of three distinct enzymes working in sequence. E1 (pyruvate dehydrogenase) uses thiamine pyrophosphate (TPP) as a coenzyme to decarboxylate pyruvate and transfer the remaining two-carbon unit. E2 (dihydrolipoyl transacetylase) uses lipoic acid covalently attached to the enzyme to accept this fragment and transfer it to coenzyme A, forming acetyl-CoA. E3 (dihydrolipoyl dehydrogenase) uses FAD and then NAD⁺ to reoxidize the lipoic acid, completing the catalytic cycle.

The complex requires five coenzymes derived from vitamins, making it exquisitely sensitive to nutritional deficiencies. A useful mnemonic, "Tender Loving Care For Nancy," helps recall these cofactors: Thiamine (TPP), Lipoic acid, CoA (from pantothenic acid), FAD (from riboflavin), and NAD⁺ (from niacin).

PDH Regulation

Given its irreversible nature and position as the gateway to complete oxidation, PDH is tightly regulated through both covalent modification and allosteric mechanisms. PDH kinase phosphorylates the E1 subunit and inactivates the complex, while PDH phosphatase removes the phosphate and restores activity.

The kinase is activated when energy supplies are abundant: high ratios of ATP/ADP, NADH/NAD⁺, and acetyl-CoA/CoA all stimulate phosphorylation and inhibit PDH. Conversely, when energy is needed, high ADP, NAD⁺, and pyruvate levels inhibit the kinase, allowing PDH to remain active. Calcium ions, which increase during muscle contraction when ATP demand rises, activate the phosphatase and stimulate PDH activity. Insulin also promotes PDH activity in fed states by activating the phosphatase.

<image>Panel A: PDH complex structure with E1 (blue), E2 (green), E3 (yellow) subunits showing substrate flow from pyruvate to acetyl-CoA. Panel B: Five coenzymes labeled: TPP at E1, lipoic acid swinging between E1-E2, CoA at E2, FAD and NAD+ at E3. Panel C: Regulatory phosphorylation cycle with PDH kinase (ATP, NADH, acetyl-CoA activated) inactivating and PDH phosphatase (Ca2+, insulin, ADP activated) activating. Panel D: Overall reaction equation and vitamin source table (TPP-B1, CoA-B5, FAD-B2, NAD-B3).</image>

III. The Eight Reactions of the TCA Cycle

Step 1: Citrate Synthase

The cycle begins when citrate synthase catalyzes the condensation of the two-carbon acetyl group from acetyl-CoA with the four-carbon oxaloacetate, producing the six-carbon citrate: Acetyl-CoA + Oxaloacetate + H₂O → Citrate + CoA-SH. This highly exergonic reaction is essentially irreversible under cellular conditions and represents a regulatory point. The enzyme is inhibited by its products (citrate, CoA-SH), by ATP, and by NADH—all signals of energy abundance.

Step 2: Aconitase

Aconitase catalyzes the isomerization of citrate to isocitrate through a dehydration-rehydration sequence via the intermediate cis-aconitate: Citrate ⇌ Isocitrate. The enzyme contains an iron-sulfur cluster essential for catalysis, making it sensitive to oxidative stress and iron deficiency. This rearrangement positions the hydroxyl group for the oxidation that follows.

Step 3: Isocitrate Dehydrogenase — The Rate-Limiting Step

Isocitrate dehydrogenase catalyzes the first oxidative decarboxylation of the cycle: Isocitrate + NAD⁺ → α-Ketoglutarate + CO₂ + NADH + H⁺. This irreversible reaction produces the first NADH and releases the first CO₂ of the cycle. As the rate-limiting step, isocitrate dehydrogenase serves as the primary control point for cycle flux. ADP and calcium ions activate the enzyme, stimulating the cycle when energy is needed or during muscle contraction. ATP and NADH inhibit the enzyme when energy supplies are adequate.

Step 4: α-Ketoglutarate Dehydrogenase Complex

The α-ketoglutarate dehydrogenase complex catalyzes the second oxidative decarboxylation: α-Ketoglutarate + NAD⁺ + CoA-SH → Succinyl-CoA + CO₂ + NADH + H⁺. This complex is structurally and mechanistically analogous to the pyruvate dehydrogenase complex, requiring the same five coenzymes (TPP, lipoic acid, CoA, FAD, NAD⁺). The reaction produces the second NADH and releases the second CO₂ of the cycle. At this point, both carbons that entered as acetyl-CoA have been released as CO₂, although isotope labeling studies show these are not the same carbon atoms—they are carbons from previous turns of the cycle.

Like isocitrate dehydrogenase, this enzyme is activated by calcium and inhibited by ATP, NADH, and its product succinyl-CoA.

<image>Panel A: Citrate synthase (blue regulatory box) combining acetyl-CoA (2C) with oxaloacetate (4C) to form citrate (6C). Panel B: Aconitase converting citrate to isocitrate, then isocitrate dehydrogenase (red box, rate-limiting) producing alpha-ketoglutarate (5C) with CO2 and NADH release. Panel C: Alpha-ketoglutarate dehydrogenase complex (green box) producing succinyl-CoA (4C) with CO2 and NADH release. Panel D: Regulatory annotations showing activators (Ca2+, ADP in green) and inhibitors (ATP, NADH, citrate, succinyl-CoA in red) for each enzyme.</image>

Step 5: Succinyl-CoA Synthetase

This step captures the energy of the thioester bond in succinyl-CoA to drive GTP synthesis: Succinyl-CoA + GDP + Pᵢ ⇌ Succinate + GTP + CoA-SH. This is the only substrate-level phosphorylation in the TCA cycle—GTP is produced directly without the electron transport chain. The GTP is energetically equivalent to ATP (nucleoside diphosphate kinase readily interconverts them). The reaction is reversible and is not a regulatory point.

Step 6: Succinate Dehydrogenase

Succinate dehydrogenase oxidizes succinate to fumarate: Succinate + FAD → Fumarate + FADH₂. This reaction is unique among TCA cycle reactions because the enzyme uses FAD rather than NAD⁺ as the electron acceptor. The enzyme is embedded directly in the inner mitochondrial membrane and constitutes Complex II of the electron transport chain—the FADH₂ generated transfers its electrons directly into the chain without the intermediacy of soluble carriers. The competitive inhibitor malonate resembles succinate and has been used experimentally to study the cycle.

Step 7: Fumarase

Fumarase catalyzes the stereospecific hydration of fumarate to L-malate: Fumarate + H₂O ⇌ L-Malate. This simple, reversible reaction adds water across the double bond, producing only the L-stereoisomer of malate.

Step 8: Malate Dehydrogenase

The final step regenerates oxaloacetate: L-Malate + NAD⁺ ⇌ Oxaloacetate + NADH + H⁺. This reaction produces the third and final NADH of the cycle. Although the equilibrium strongly favors malate, the reaction is pulled forward by the highly favorable citrate synthase reaction that immediately consumes oxaloacetate. With oxaloacetate regenerated, the cycle is complete and ready to accept another acetyl-CoA.

<image>Panel A: Step 5 succinyl-CoA synthetase converting succinyl-CoA to succinate with GDP + Pi to GTP (substrate-level phosphorylation in yellow). Panel B: Step 6 succinate dehydrogenase (Complex II notation) converting succinate to fumarate with FAD to FADH2 (orange). Panel C: Step 7 fumarase adding H2O producing L-malate, step 8 malate dehydrogenase producing oxaloacetate with NAD+ to NADH (purple). Panel D: Cycle completion arrow back to citrate synthase with total yield summary: 1 GTP, 1 FADH2, 1 NADH.</image>

IV. Energy Yield from One Acetyl-CoA

Each turn of the TCA cycle generates reduced coenzymes and GTP that represent the energy captured from oxidizing the two-carbon acetyl unit. The direct products from one acetyl-CoA entering the cycle are: three NADH, one FADH₂, and one GTP.

When these reduced coenzymes are oxidized by the electron transport chain, they drive ATP synthesis through oxidative phosphorylation. Current estimates based on the proton motive force suggest that each NADH yields approximately 2.5 ATP, while each FADH₂ yields approximately 1.5 ATP. Thus, one acetyl-CoA generates approximately: (3 × 2.5) + (1 × 1.5) + 1 = 7.5 + 1.5 + 1 = 10 ATP equivalents.

For the complete oxidation of one glucose molecule, the accounting is more extensive. Glycolysis produces 2 ATP and 2 NADH in the cytoplasm. The two pyruvates enter mitochondria and are converted to two acetyl-CoA molecules, producing 2 NADH. The two turns of the TCA cycle produce 6 NADH, 2 FADH₂, and 2 GTP. Summing these contributions and converting NADH and FADH₂ to ATP equivalents (with the cytoplasmic NADH from glycolysis entering via shuttle systems) yields a total of approximately 30-32 ATP per glucose—a remarkable 15-16 fold improvement over the 2 ATP from anaerobic glycolysis alone.

<image>Panel A: Glycolysis section showing 2 ATP direct and 2 NADH cytoplasmic production separated by membrane line. Panel B: PDH section (x2) showing 2 NADH production and TCA cycle (x2) with 2 GTP, 6 NADH, 2 FADH2. Panel C: Conversion table showing cytoplasmic NADH to 1.5-2.5 ATP, mitochondrial NADH to 2.5 ATP, FADH2 to 1.5 ATP. Panel D: Final calculation yielding 30-32 ATP total with pie chart showing relative contributions from each pathway.</image>

V. Regulation of the TCA Cycle

The TCA cycle is regulated to match energy production to cellular energy demands. Regulation occurs primarily at the three irreversible reactions catalyzed by citrate synthase, isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase.

Energy Status: The Master Regulator

The ratios of ATP/ADP and NADH/NAD⁺ provide the primary signals controlling cycle flux. When energy is abundant and these ratios are high, the three regulatory enzymes are inhibited, slowing the cycle. When energy is depleted and ADP and NAD⁺ accumulate, the enzymes are activated, accelerating oxidation to replenish ATP.

Calcium Signaling

Calcium ions activate both isocitrate dehydrogenase and α-ketoglutarate dehydrogenase. In muscle, the same calcium release that triggers contraction also stimulates the TCA cycle, elegantly coupling energy consumption with energy production. The increased demand for ATP during contraction is matched by increased cycle flux.

Substrate Availability

The cycle cannot operate without its substrates. Acetyl-CoA availability, determined by the rate of fatty acid oxidation or pyruvate dehydrogenase activity, controls entry into the cycle. Oxaloacetate availability is equally critical—if oxaloacetate is diverted to other pathways (such as gluconeogenesis), cycle flux diminishes regardless of acetyl-CoA supply.

Product Inhibition

Each of the regulated enzymes is inhibited by its products. Citrate inhibits citrate synthase, succinyl-CoA inhibits α-ketoglutarate dehydrogenase, and NADH inhibits all three. This product inhibition prevents wasteful overproduction when downstream pathways are saturated.

<image>Panel A: Citrate synthase regulatory box with inhibitors (ATP, NADH, citrate, succinyl-CoA in red zone) on simplified circular pathway. Panel B: Isocitrate dehydrogenase (rate-limiting label) with activators (ADP, Ca2+ in green) and inhibitors (ATP, NADH in red). Panel C: Alpha-ketoglutarate dehydrogenase with Ca2+ activator and ATP, NADH, succinyl-CoA inhibitors with feedback connection lines. Panel D: Calcium-muscle contraction panel showing Ca2+ release linking energy demand to TCA cycle activation.</image>

VI. Anaplerotic Reactions

The TCA cycle intermediates serve not only as carriers of carbon through the oxidative pathway but also as precursors for numerous biosynthetic reactions. When intermediates are withdrawn for biosynthesis, they must be replenished to prevent the cycle from running down. Anaplerotic reactions ("filling up" reactions) serve this essential function.

Pyruvate Carboxylase: The Major Anaplerotic Enzyme

The most important anaplerotic reaction is catalyzed by pyruvate carboxylase: Pyruvate + CO₂ + ATP → Oxaloacetate + ADP + Pᵢ. This biotin-dependent enzyme operates in the mitochondrial matrix and directly replenishes oxaloacetate. Critically, acetyl-CoA is an obligate activator of pyruvate carboxylase—when acetyl-CoA accumulates because oxaloacetate is limiting for citrate synthase, pyruvate carboxylase is activated to replenish oxaloacetate and restore cycle flux.

Amino Acid Contributions

Several amino acids feed directly into TCA cycle intermediates. Glutamate can be converted to α-ketoglutarate through transamination or oxidative deamination. Aspartate similarly yields oxaloacetate. The branched-chain amino acids valine and isoleucine are degraded to succinyl-CoA through a complex series of reactions. These amino acid inputs become particularly important during fasting or in high-protein diets.

Propionyl-CoA Pathway

Odd-chain fatty acids and certain amino acids (valine, isoleucine, methionine, threonine) generate propionyl-CoA, a three-carbon unit. Through a biotin- and vitamin B12-dependent pathway, propionyl-CoA is converted to methylmalonyl-CoA and then to succinyl-CoA, entering the TCA cycle. This represents the only mechanism by which fatty acid carbons can contribute to net glucose synthesis (since succinyl-CoA carbons can exit as oxaloacetate for gluconeogenesis).

<image>Panel A: Pyruvate carboxylase (major arrow) converting pyruvate + CO2 + ATP to oxaloacetate with biotin cofactor and acetyl-CoA activator noted. Panel B: Glutamate entering as alpha-ketoglutarate and aspartate entering as oxaloacetate via transaminases. Panel C: Valine/isoleucine and odd-chain fatty acids entering as succinyl-CoA via B12-dependent propionyl-CoA pathway. Panel D: Side panel explaining anaplerosis importance when citrate exits for fatty acid synthesis or oxaloacetate used for gluconeogenesis.</image>

VII. Cataplerotic Reactions: The Biosynthetic Roles of TCA Intermediates

Just as anaplerotic reactions replenish cycle intermediates, cataplerotic reactions remove them for biosynthetic purposes. The TCA cycle serves as a distribution hub, providing carbon skeletons for diverse synthetic pathways.

Citrate can be transported from the mitochondrial matrix to the cytoplasm, where ATP-citrate lyase cleaves it to regenerate acetyl-CoA and oxaloacetate. This cytoplasmic acetyl-CoA serves as the substrate for fatty acid synthesis and cholesterol biosynthesis. When the cycle is generating citrate faster than it needs for energy production, citrate export diverts carbon toward lipid storage.

Alpha-ketoglutarate provides the carbon skeleton for the synthesis of glutamate, glutamine, and proline—important amino acids that also serve as nitrogen carriers and neurotransmitters. The urea cycle connects to the TCA cycle through the aspartate-argininosuccinate shunt.

Succinyl-CoA is essential for heme biosynthesis, combining with glycine in the first committed step of the pathway that produces the iron-binding porphyrin ring found in hemoglobin, myoglobin, and cytochromes.

Oxaloacetate serves as a precursor for gluconeogenesis (after conversion to phosphoenolpyruvate) and for the synthesis of aspartate and the pyrimidine nucleotides.

This amphibolic nature—simultaneously serving catabolic and anabolic functions—makes the TCA cycle the central metabolic hub of the cell.

VIII. Clinical Correlations

Thiamine (Vitamin B1) Deficiency

Thiamine deficiency impairs both the pyruvate dehydrogenase complex and the α-ketoglutarate dehydrogenase complex, as both require thiamine pyrophosphate (TPP) as a coenzyme. The clinical presentations reflect the tissues most dependent on aerobic metabolism.

Beriberi manifests as peripheral neuropathy (dry beriberi) and high-output cardiac failure with edema (wet beriberi) due to impaired oxidative metabolism in nerves and heart muscle. Wernicke-Korsakoff syndrome occurs primarily in alcoholics, presenting acutely as Wernicke encephalopathy (confusion, ophthalmoplegia, ataxia) and chronically as Korsakoff syndrome (profound anterograde amnesia with confabulation). Lactic acidosis accompanies thiamine deficiency because pyruvate cannot enter the TCA cycle and is shunted to lactate instead.

Arsenic Poisoning

Arsenic compounds bind to the sulfhydryl groups of lipoic acid, inactivating the PDH complex and α-ketoglutarate dehydrogenase. The clinical presentation resembles severe thiamine deficiency, with neurological symptoms, gastrointestinal distress, and lactic acidosis.

Inherited Enzyme Deficiencies

Fumarase deficiency is a rare autosomal recessive disorder causing severe developmental abnormalities, encephalopathy, and seizures. Affected individuals excrete elevated fumarate in urine. The accumulation of fumarate may stabilize hypoxia-inducible factors, potentially explaining associations with renal cell carcinoma in heterozygous carriers.

Leigh syndrome represents a heterogeneous group of mitochondrial disorders affecting the PDH complex, components of the electron transport chain, or other mitochondrial functions. Patients develop progressive neurodegeneration with characteristic symmetric lesions in the basal ganglia and brainstem on MRI. Lactic acidosis and movement disorders are prominent features, with respiratory failure often the cause of death.

IDH Mutations in Cancer

Somatic mutations in isocitrate dehydrogenase genes (IDH1 and IDH2) occur frequently in gliomas and acute myeloid leukemia (AML). These mutations are not simple loss-of-function mutations—instead, they confer a neomorphic enzyme activity that produces 2-hydroxyglutarate (2-HG), an "oncometabolite" that inhibits α-ketoglutarate-dependent enzymes involved in histone and DNA demethylation. The resulting epigenetic dysregulation promotes tumorigenesis. This discovery has led to targeted therapies: ivosidenib (IDH1 inhibitor) and enasidenib (IDH2 inhibitor) are approved for treatment of IDH-mutant AML.

<image>Panel A: Leigh syndrome brain MRI showing symmetric hyperintense lesions in basal ganglia and brainstem with clinical features listed. Panel B: Thiamine deficiency showing peripheral neuropathy (dry beriberi), cardiac edema (wet beriberi), and Wernicke-Korsakoff brain lesions. Panel C: 2-HG oncometabolite mechanism with mutant IDH1/2 converting alpha-KG to 2-HG inhibiting TET enzymes causing DNA hypermethylation. Panel D: Targeted therapy structures ivosidenib and enasidenib for IDH-mutant cancers.</image>

IX. Integration with Other Pathways

The TCA cycle sits at the crossroads of metabolism, connected to virtually every major pathway.

From glycolysis, pyruvate enters the mitochondria and is converted to acetyl-CoA by the PDH complex. In the reverse direction, oxaloacetate can be converted to phosphoenolpyruvate for gluconeogenesis (the enzyme pyruvate carboxylase provides the anaplerotic oxaloacetate, and PEPCK converts it to PEP).

From fatty acid metabolism, beta-oxidation of fatty acids generates acetyl-CoA that enters the cycle. In the fed state, citrate exports acetyl-CoA to the cytoplasm for fatty acid synthesis. This bidirectional flux makes the cycle central to metabolic flexibility—whether the body stores fat or burns it, the TCA cycle is involved.

From amino acid metabolism, transamination reactions link α-ketoglutarate to glutamate and oxaloacetate to aspartate. The urea cycle, which disposes of nitrogen, connects through the aspartate-argininosuccinate shunt: aspartate donates a nitrogen to the urea cycle, with fumarate returning to the TCA cycle.

This integration explains why defects in the TCA cycle have such widespread consequences—the cycle is not an isolated pathway but the metabolic center of the cell.

Summary

The tricarboxylic acid (TCA) cycle, located in the mitochondrial matrix, represents the final common pathway for oxidizing acetyl-CoA derived from carbohydrates, fats, and proteins. The cycle consists of eight enzymatic steps that oxidize the two-carbon acetyl unit to two molecules of CO₂ while generating three NADH, one FADH₂, and one GTP per turn. The pyruvate dehydrogenase complex serves as the gateway, irreversibly converting pyruvate to acetyl-CoA while producing NADH and CO₂. Three irreversible enzymes—citrate synthase, isocitrate dehydrogenase (rate-limiting), and α-ketoglutarate dehydrogenase—are regulated primarily by energy status (ATP/ADP and NADH/NAD⁺ ratios) and calcium ions. Anaplerotic reactions replenish cycle intermediates that are withdrawn for biosynthesis, with pyruvate carboxylase being the most important. The complete oxidation of one glucose molecule yields approximately 30-32 ATP. Clinical conditions affecting the cycle include thiamine deficiency (impairing PDH and α-ketoglutarate dehydrogenase), Leigh syndrome, and IDH mutations in cancer that produce the oncometabolite 2-hydroxyglutarate.

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown